These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3770993)

  • 1. Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: a multivariate analysis approach.
    Brentani MM; Franco EL; Oshima CT; Pacheco MM
    Int J Cancer; 1986 Nov; 38(5):637-42. PubMed ID: 3770993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of androgen receptor in primary breast carcinoma and its relation with clinicopathologic features, estrogen, progesterone, and her-2 receptor status.
    Vellaisamy G; Tirumalae R; Inchara YK
    J Cancer Res Ther; 2019; 15(5):989-993. PubMed ID: 31603099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers.
    Ogawa Y; Hai E; Matsumoto K; Ikeda K; Tokunaga S; Nagahara H; Sakurai K; Inoue T; Nishiguchi Y
    Int J Clin Oncol; 2008 Oct; 13(5):431-5. PubMed ID: 18946753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status.
    Zhang X; Eliassen AH; Tamimi RM; Hazra A; Beck AH; Brown M; Collins LC; Rosner B; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):962-8. PubMed ID: 25855627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of androgen receptor in breast carcinoma and its relationship with estrogen receptor, progesterone receptor and HER2 status].
    Chen J; Zhang X; Tian R; Liu Y; Dong HM; Guo RF; Liang HY
    Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):743-6. PubMed ID: 21215164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does androgen receptor have a prognostic role in patients with estrogen/progesterone-negative and c-erbB-2-positive breast cancer?
    Arslan C; Isik M; Guler G; Kulac I; Solak M; Turker B; Ozisik Y; Altundag K
    Am Surg; 2012 Sep; 78(9):992-9. PubMed ID: 22964210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters.
    Kuenen-Boumeester V; Van der Kwast TH; Claassen CC; Look MP; Liem GS; Klijn JG; Henzen-Logmans SC
    Eur J Cancer; 1996 Aug; 32A(9):1560-5. PubMed ID: 8911118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone receptors in breast cancer: more than estrogen receptors.
    Lamb CA; Vanzulli SI; Lanari C
    Medicina (B Aires); 2019; 79(Spec 6/1):540-545. PubMed ID: 31864223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer.
    Tokunaga E; Hisamatsu Y; Taketani K; Yamashita N; Akiyoshi S; Okada S; Tanaka K; Saeki H; Oki E; Aishima S; Oda Y; Morita M; Maehara Y
    Cancer Med; 2013 Dec; 2(6):763-73. PubMed ID: 24403250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator expression and steroid hormone receptors in female breast cancer: a multifactorial study.
    Pacheco MM; Brentani MM; Franco EL; Fontelles JA; Chamone DF; Marques LA
    Int J Cancer; 1988 Jun; 41(6):798-804. PubMed ID: 3372056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor expression shows distinctive significance in ER positive and negative breast cancers.
    Tsang JY; Ni YB; Chan SK; Shao MM; Law BK; Tan PH; Tse GM
    Ann Surg Oncol; 2014 Jul; 21(7):2218-28. PubMed ID: 24639191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
    Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
    Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer.
    Agrawal A; Ziolkowski P; Grzebieniak Z; Jelen M; Bobinski P; Agrawal S
    Appl Immunohistochem Mol Morphol; 2016 Sep; 24(8):550-5. PubMed ID: 26230371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen pathway dysregulation in BRCA1-mutated breast tumors.
    Berns EM; Dirkzwager-Kiel MJ; Kuenen-Boumeester V; Timmermans M; Verhoog LC; van den Ouweland AM; Meijer-Heijboer H; Klijn JG; van der Kwast TH
    Breast Cancer Res Treat; 2003 May; 79(1):121-7. PubMed ID: 12779088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of androgen receptor in breast cancer & its correlation with other steroid receptors & growth factors.
    Mishra AK; Agrawal U; Negi S; Bansal A; Mohil R; Chintamani C; Bhatnagar A; Bhatnagar D; Saxena S
    Indian J Med Res; 2012 Jun; 135(6):843-52. PubMed ID: 22825604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative activity and steroid hormone receptor status in male breast carcinoma.
    Muñoz de Toro MM; Maffini MV; Kass L; Luque EH
    J Steroid Biochem Mol Biol; 1998 Nov; 67(4):333-9. PubMed ID: 9883990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours.
    Hall RE; Clements JA; Birrell SN; Tilley WD
    Br J Cancer; 1998 Aug; 78(3):360-5. PubMed ID: 9703283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
    Shahi KS; Bhandari G; Singh A
    J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis.
    Suzuki R; Orsini N; Saji S; Key TJ; Wolk A
    Int J Cancer; 2009 Feb; 124(3):698-712. PubMed ID: 18988226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.